NCT07389161Recruiting
Uneven Nutrition and Life Style as IBD Triggers in Adolescents and Adults
Source: ClinicalTrials.gov · Last updated 29 Apr 2026
Brief summary (registry, in English)
The aims of the study are 1. to determine the effect on dysbiosis, permeability and inflammatory activity after administration of a Mediterranean like diet (a Nordic equivalent, "Nordiet"), 2. to investigate life style related factors, such as exercise, psychosexual health and quality of life and their relation to the disease activity.
- Status (registry)
- Recruiting
- Study type
- Interventional
- Enrollment
- 160 (estimated)
- First submitted
- 16 Dec 2025
- Start date
- 28 Apr 2026
- Primary completion date
- 30 Jun 2029
- Lead sponsor
- Region Skane
- Diseases
- Crohn's disease, Ulcerative colitis
- NCT number
- NCT07389161
What you commit to
- Study type: Interventional
- Planned participants: 160
- From 28 Apr 2026 to the primary completion date, 30 Jun 2029
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other illness
- Inactive disease
Other
- Proctitis alone
- Severe flare up requiring in-patient care
- Planned change of treatment
- Antibiotic treatment during the last month
- Pregnancy
- Inability to understand Swedish
- Multimorbidity
Who the study is looking for
- IBD, i.e., Mb Crohn or ulcerrative colitis
- Moderatively active disease (calprotectin 200-600)
Age in the registry: 18 years to 35 years · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Skåne University Hospital Coordinator of this site? Confirm its status | Malmö | Sweden | Recruiting |
This page is information, not medical advice. Discuss any trial with your doctor.